Dr. Thierry Lacaze is the RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network Nominated Principal Investigator and the Scientific Director of the Maternal Infant Child and Youth Research Network since 2018. Dr. Lacaze is a neonatologist by training and Clinical Professor of Pediatrics at the University of Calgary.
Breanne Stewart is the Network Director for RareKids-CAN, where she provides strategic leadership, oversees network operations, and fosters collaboration among stakeholders. Breanne is a registered nurse with over 10 years of experience in clinical trials. For the past 6 years, she has supported pediatric clinical trials through the Maternal Infant Child and Youth Research Network (MICYRN).
This week's core session of Grand Rounds will provide an in-depth look at RareKids-CAN, a CIHR Rare Disease Research Initiative launched in 2023 in collaboration with the Government of Canada’s National Strategy for Drugs for Rare Diseases. It will cover:
- An overview of the network's structure and objectives
- A description of its key activities and comprehensive service offerings
- Insights into how RareKids-CAN supports investigators and study teams conducting pediatric rare disease research in Canada.